Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$995.83M+0.2%$994.23M-1.1%$1B-2.6%$1.03B+4.9%$984.17M-1.8%
$12.2M-7.6%$13.2M+9.1%$12.1M0.0%$12.1M+4.3%$11.6M-21.1%
$159.42M-18.7%$196.14M+10.4%$177.59M-7.3%$191.55M+7.7%$177.8M-9.2%
$22.38M+26.9%$17.63M-24.2%$23.27M+36.5%$17.05M+29.8%$13.14M-23.8%
$67.15M-14.2%$78.28M-8.1%$85.16M-28.7%$119.51M-0.7%$120.36M+17.9%
$47K-96.9%$1.5M-36.5%$2.37M+1,187%$184K-90.8%$2.01M-69.4%
$31.58M+19.2%$26.49M+53.2%$17.28M-46.3%$32.2M+35.0%$23.85M-42.4%
$41.25M0.0%$41.25M0.0%$41.25M0.0%$41.25M-23.3%
$15.86M-92.9%$222.9M+4,374%$4.98M-75.8%$20.63M+95.0%$10.58M-69.3%
$119.9M$133.8M+33.6%$100.13M+34.1%$74.67M
12%13.3%+3.6pp9.7%+2.1pp7.6%
$26.74M+12.5%$23.78M-6.4%$25.4M-15.2%$29.97M+7.5%$27.88M-1.2%
$1.03M+1.6%$1.02M-28.5%$1.42M+29.6%$1.1M-21.9%$1.4M-23.5%
-$124.13M-$22.62M-14,787%$154K+101%-$12.21M+46.2%
-$117.98M$3.38M
-$15.14M$31.64M+69.0%$18.73M+85.4%$10.1M
-$14.84M+94.6%-$276.56M-608%$54.42M+4.0%$52.33M+105%$25.47M
-1.5%+26.3pp-27.8%-33.2pp5.4%+0.3pp5.1%+2.5pp2.6%
$41K-84.5%$265K-76.6%$1.13M+209%$367K-10.3%$409K-45.3%
-$0.30+94.6%-$5.56-605%$1.10+3.8%$1.06+112%$0.50
-$0.30+94.6%-$5.57-602%$1.11+4.7%$1.06+112%$0.50
49M-1.2%49.6M+0.3%49.4M+0.2%49.3M-3.0%50.9M-1.5%
49M-1.2%49.6M+0.7%49.2M+0.1%49.1M-3.0%50.7M-1.4%
$47K-96.9%$1.5M-36.5%$2.37M+1,187%$184K-90.8%$2.01M-69.4%
-$500K-156%$900K-50.0%$1.8M$1.5M-73.7%
$8.3M+4,050%$200K$0-100%$6.8M+119%$3.1M+3,000%
$22.38M+26.9%$17.63M-24.2%$23.27M+36.5%$17.05M+29.8%$13.14M-23.8%
$2.4M-50.5%$4.85M+246%$1.4M-61.1%$3.6M-11.0%$4.05M-66.6%
$15.35M-27.0%$21.01M-23.3%$27.4M-58.1%$65.38M+0.2%$65.26M+58.3%
$0$7.4M+76.2%$4.2M-32.3%$6.2M
$1.89M0.0%$1.89M0.0%$1.89M0.0%$1.89M-2.7%
615K-33.0%918K-18.8%1.1M+0.3%1.1M+17.7%958K+80.8%
-$17.8M-363%$6.78M-72.3%$24.48M+152%-$46.99M-280%$26.16M+531%
-$34.1M$29.27M-80.6%$151.11M+94.8%$77.57M+123%
-$393K-354%$155K-78.9%$735K-74.6%$2.89M+745%-$449K-131%
-$34.5M$30.01M-80.5%$154M+99.7%$77.12M+123%
75%-15.0%90%70%-20.0%
55%-25.0%80%60%-20.0%
$2.72M0.0%$2.72M0.0%$2.72M0.0%$2.72M-70.1%
$24.36M0.0%$24.36M0.0%$24.36M0.0%$24.36M+12.6%
$2.43M0.0%$2.43M0.0%$2.43M0.0%$2.43M-20.1%
$850K0.0%$850K0.0%$850K0.0%$850K+13.3%
-$10.19M0.0%-$10.19M0.0%-$10.19M0.0%-$10.19M+19.4%
-$5.6M0.0%-$5.6M0.0%-$5.6M0.0%-$5.6M-224%
-$18.84M0.0%-$18.84M0.0%-$18.84M0.0%-$18.84M-12.2%
-$29.42M+51.1%-$60.17M-$21.99M-15.5%-$19.04M+54.1%
-$3.05M0.0%-$3.05M0.0%-$3.05M0.0%-$3.05M-25.5%
$3.28M0.0%$3.28M0.0%$3.28M0.0%$3.28M+1,258%
$9.1M0.0%$9.1M0.0%$9.1M0.0%$9.1M+320%
-$3.23M0.0%-$3.23M0.0%-$3.23M0.0%-$3.23M
$0$0$0$0-100%
$1.21M0.0%$1.21M0.0%$1.21M0.0%$1.21M+131%
$2.08M0.0%$2.08M0.0%$2.08M0.0%$2.08M-22.1%
5.2%
$0.010.0%$0.010.0%$0.010.0%$0.01+25.7%
3.2%
$1.81M0.0%$1.81M0.0%$1.81M0.0%$1.81M-10.1%
$497.75K0.0%$497.75K0.0%$497.75K0.0%$497.75K-63.8%
$0$0$0$0-100%
-$3.38M0.0%-$3.38M0.0%-$3.38M0.0%-$3.38M-502%
-$7.25K0.0%-$7.25K0.0%-$7.25K0.0%-$7.25K
$1.81M0.0%$1.81M0.0%$1.81M0.0%$1.81M-10.1%
$3.48M0.0%$3.48M0.0%$3.48M0.0%$3.48M+618%
$3.5K0.0%$3.5K0.0%$3.5K0.0%$3.5K
$0$0$0$0-100%
$0$0$0$0-100%
$6.73M0.0%$6.73M0.0%$6.73M0.0%$6.73M-12.9%
25%
10%
$41.3M-8.4%$45.1M+0.7%$44.8M+1.1%$44.3M+2.1%$43.4M-10.3%
$1.25M-68.2%$3.93M$12.67M+141%$5.27M+139%
$0.51+168%-$0.74-304%$0.36+38.5%$0.26-6.8%$0.28-43.7%
21%
$4.25K0.0%$4.25K0.0%$4.25K0.0%$4.25K
0%
$1.57M0.0%$1.57M0.0%$1.57M0.0%$1.57M
-6.3%
-$0.010.0%-$0.010.0%-$0.010.0%-$0.01
-5%
$1.24M0.0%$1.24M0.0%$1.24M0.0%$1.24M
-4.5%
2.7%
$0$0$0$0
-$117.98M$3.38M
$38.5M
$340.99M
-$18.55M-366%$6.97M$62.86M+104%$30.79M+149%
$41.25M0.0%$41.25M0.0%$41.25M0.0%$41.25M-23.3%
$46.65M$4M
$15.86M-92.9%$222.9M+4,374%$4.98M-75.8%$20.63M+95.0%$10.58M-69.3%
-$72.66M0.0%-$72.66M0.0%-$72.66M0.0%-$72.66M-0.1%
$47.79M0.0%$47.79M0.0%$47.79M0.0%$47.79M-50.1%
-$29.94M+89.8%-$294.1M-437%$87.2M+22.1%$71.42M+98.5%$35.98M
$10.57M0.0%$10.57M0.0%$10.57M0.0%$10.57M
-$5.22M0.0%-$5.22M0.0%-$5.22M0.0%-$5.22M
$972K0.0%$972K0.0%$972K0.0%$972K
$1.12M0.0%$1.12M0.0%$1.12M0.0%$1.12M
$1.73M-93.6%$26.95M+44.1%$18.7M-67.0%$56.66M+227%$17.32M-45.0%
$20.46M$24.51M$25.25M+452%
$65.32M+336%-$27.63M-3.9%-$26.6M-145%-$10.86M-137%$29.35M+986%
-$135K-101%$15.19M+1,479%-$1.1M$9.17M
$5.2M+120%-$25.82M-9.3%-$23.63M-289%$12.52M+1,132%-$1.21M-124%
-$83.76M$0-100%$42.88M+80.7%$23.73M+55.5%$15.26M+160%
-$26M-844%$3.5M-88.8%$31.33M$21.88M+826%
$8.52M$43.07M+64.0%$26.26M+748%-$4.05M-132%
$131.4M$800K-38.5%$1.3M+44.4%$900K
$0+100%-$186K-187%$213K+27.5%$167K-5.1%$176K
$500K0.0%$500K0.0%$500K0.0%$500K
$28.99M+58.3%$18.31M-35.3%$28.29M+8.7%$26.03M-10.5%$29.09M+16.9%
$6.13M0.0%$6.13M0.0%$6.13M0.0%$6.13M-11.6%
$1.49M-14.8%$1.75M$0-100%$4.31M-36.3%$6.76M-75.0%
$347.72M+770%-$51.86M+66.0%-$152.62M+32.7%-$226.92M-115%-$105.33M-38.8%
-$407.85M-339%-$92.81M-175%-$33.7M+9.8%-$37.34M+17.9%-$45.48M+40.2%
$41.08M-72.2%$147.52M-31.0%$213.83M+4.5%$204.6M+19.2%$171.7M+7.7%
$41K-84.5%$265K-76.6%$1.13M+209%$367K-10.3%$409K-45.3%
-$14.33M+94.8%-$276.13M-603%$54.94M+4.0%$52.85M+105%$25.8M
$3.55M+49.3%$2.38M+643%$320K-86.6%$2.38M+80.5%$1.32M
33
-$25.18M-249%$16.86M+163%-$26.96M-122%$121.22M+101%$60.38M+146%
$894K$462K+1.1%$457K+12.0%$408K-26.9%
-$24.29M-209%$22.34M+184%-$26.5M-122%$121.68M+100%$60.79M+143%
-$23.85M
-$23.85M
-$19.26M-197%$19.83M+179%-$25.15M-125%$98.78M+89.6%$52.1M+142%
-$1.41M0.0%-$1.41M0.0%-$1.41M0.0%-$1.41M-146%
-$4.59M-275%$2.62M+375%-$952K-105%$20.37M+113%$9.55M+151%
$34.68M-$1.04M-$3.73M+84.7%
-$124.13M-$22.62M-14,787%$154K+101%-$12.21M+46.2%
$25.36M+76.0%$14.41M+15.4%$12.49M-56.1%$28.47M+84.5%$15.43M-46.2%
$0$19.14M
$1.46M+794%-$210K+92.5%-$2.81M-1,055%-$243K-134%-$104K+97.9%
$208.29M+216,864%$96K+3.2%$93K-98.7%$7.35M-97.9%$353.13M+284,684%
$17.3M+44.2%$12M-14.2%$13.99M-23.0%$18.16M+26.8%$14.32M-23.2%
$405.01M$0$0$0$0
$8.49M+12.7%$7.53M+69.1%$4.45M+59.8%$2.79M-47.4%$5.3M-30.3%
$55.91M-37.1%$88.95M+150%$35.58M+0.8%$35.3M-40.5%$59.32M-21.5%
$912.46M+482%$156.67M+45.7%$107.5M-80.3%$547.02M+31.4%$416.34M+297%
-$2M-49.8%-$1.34M+78.6%-$6.23M+3.5%-$6.46M$0+100%
$2.92M-15.7%$3.47M-1.9%$3.53M+601%$504K-68.5%$1.6M-27.7%
$60.1M$17.44M
$1.22M+72.0%$711K+35,450%$2K+100%$1K$0-100%
$3.75M0.0%$3.75M0.0%$3.75M0.0%$3.75M
$21.6M
$47K-96.9%$1.5M-36.5%$2.37M+1,187%$184K-90.8%$2.01M-69.4%
$355.68M+71.1%$207.82M-18.1%$253.79M-65.6%$738.31M+394%$149.39M-15.5%
$1.1M0.0%$1.1M0.0%$1.1M0.0%$1.1M
-$16.29M-$5.88M+73.5%-$22.16M-118%-$10.16M
-$284K$381K+310%$93K+128%
$995.83M+0.2%$994.23M-1.1%$1B-2.6%$1.03B+4.9%$984.17M-1.8%
$1.91M$0-100%$27K+108%$13K$0-100%
$12.2M-7.6%$13.2M+9.1%$12.1M0.0%$12.1M+4.3%$11.6M-21.1%
$22.38M+26.9%$17.63M-24.2%$23.27M+36.5%$17.05M+29.8%$13.14M-23.8%
43%
$61.63
21K
$235.95
4.1%
40K
0%
$135.00
$179.66
$1.71M$3.42M
100K0.0%100K100K0.0%
1K
$1.22M+64.4%$744K+74,300%$1K0.0%$1K0.0%$1K-99.9%
$3.55M+49.3%$2.38M+643%$320K-86.6%$2.38M+80.5%$1.32M
$2M$6.46M
-$477K$615K+487%-$159K-312%$75K-51.0%
-$434K$0+100%-$399K-116%$2.53M+395%-$858K
$0$0$0$0
$208.29M+216,864%$96K+3.2%$93K-98.6%$6.79M-98.1%$353.13M+284,684%
$338K0.0%$338K0.0%$338K0.0%$338K+68.8%
$585.5K0.0%$585.5K0.0%$585.5K0.0%$585.5K-11.6%
$971.75K0.0%$971.75K0.0%$971.75K0.0%$971.75K+356%
$131.6M$200K-89.5%$1.9M-17.4%$2.3M
$850K0.0%$850K0.0%$850K0.0%$850K+839%
-$1.14M-$10.37M+52.2%
$119.9M+10,992%-$1.1M-101%$133.8M+33.6%$100.13M+34.1%$74.67M+45.0%
$187.05M+142%$77.18M-64.8%$218.96M-0.3%$219.64M+12.6%$195.03M+27.0%
$187.05M+142%$77.18M-64.8%$218.96M-0.3%$219.64M+12.6%$195.03M+27.0%
18.8%+11.0pp7.8%-14.0pp21.8%+0.5pp21.3%+1.5pp19.8%+4.5pp
$119.9M+10,992%-$1.1M-101%$133.8M+33.6%$100.13M+34.1%$74.67M+45.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Charles River Laboratories's revenue?
Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
Is Charles River Laboratories profitable?
Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
What are Charles River Laboratories's profit margins?
Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
What is Charles River Laboratories's earnings per share?
Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
Where does Charles River Laboratories's income statement data come from?
Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.